Lv5
1190 积分 2022-10-10 加入
DS-8201a, A Novel HER2-Targeting ADC with a Novel DNA Topoisomerase I Inhibitor, Demonstrates a Promising Antitumor Efficacy with Differentiation from T-DM1
6天前
已完结
Trastuzumab Deruxtecan for HER2+ Advanced Breast Cancer
6天前
已完结
Development of a PCR method for mycoplasma testing of Chinese hamster ovary cell cultures used in the manufacture of recombinant therapeutic proteins
11天前
已完结
Detection by Polymerase Chain Reaction of all Common Mycoplasma in a Cell Culture Facility
11天前
已完结
COMPARATIVE PCR ANALYSIS FOR DETECTION OF MYCOPLASMA INFECTIONS IN CONTINUOUS CELL LINES
11天前
已完结
Detecting Mycoplasma Contamination in Cell Cultures by Polymerase Chain Reaction
11天前
已完结
Trastuzumab deruxtecan in patients with HER2-positive advanced colorectal cancer (DESTINY-CRC02): primary results from a multicentre, randomised, phase 2 trial
15天前
已完结
Immunogenic camptothesome nanovesicles comprising sphingomyelin-derived camptothecin bilayers for safe and synergistic cancer immunochemotherapy
16天前
已完结
Comprehensive preclinical pharmacokinetic evaluations of trastuzumab deruxtecan (DS-8201a), a HER2-targeting antibody-drug conjugate, in cynomolgus monkeys
1个月前
已完结
Preclinical Development of Antibody–Drug Conjugates
1个月前
已完结
皖公网安备34019202002308
